모바일 심장 텔레메트리 시스템 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the mobile cardiac telemetry systems market is projected to expand from USD 1.84 billion in 2025 and USD 2.07 billion in 2026 to USD 3.84 billion by 2031, registering a CAGR of 13.17% between 2026 to 2031.

This report is Segmented by Product Type (Lead-Based Systems, Patch-Based Systems), Component (Hardware, Software, Services), Application (Arrhythmia Monitoring, Heart Disease Diagnosis, and Others), End-User (Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Mobile Cardiac Telemetry Systems Market Trends and Insights

Increasing Burden of Cardiac Disease and Arrhythmia Detection Needs

The mobile cardiac telemetry systems market continues to benefit from the fact that cardiovascular disease remains the leading cause of death worldwide. The mobile cardiac telemetry systems market is also supported by the uneven distribution of disease burden, because low- and middle-income countries account for more than three-quarters of cardiovascular deaths and often have limited specialist capacity. That imbalance makes continuous remote monitoring more useful as an efficiency tool, especially where specialist staffing is limited and hospital capacity is constrained. The mobile cardiac telemetry systems market is therefore not only expanding in already developed settings, but is also becoming relevant in healthcare systems that need scalable cardiac surveillance models. This broad disease backdrop keeps demand tied to long-cycle clinical need rather than to short-term device replacement patterns. It also strengthens the case for continuous monitoring in chronic disease management, secondary prevention, and post-discharge care across the mobile cardiac telemetry systems market.

Shift to Continuous, Real-Time Remote Patient Monitoring

The mobile cardiac telemetry systems market is being lifted by a steady move away from episodic Holter testing toward longer and continuous rhythm surveillance. CMS coverage rules support up to 30 days of continuous monitoring, which improves the ability to detect intermittent conditions that are often missed during short monitoring windows. A 2025 multicenter stroke substudy showed that wearable ECG monitoring identified atrial fibrillation in patients with no prior AF history, which expands the clinical role of remote cardiac monitoring beyond routine cardiology use.The mobile cardiac telemetry systems market is therefore seeing its prescriber base widen into neurology and internal medicine, where follow-up rhythm surveillance is gaining clinical importance. This is helping the mobile cardiac telemetry systems market shift from a specialized diagnostic tool toward a more predictable service line linked to ongoing surveillance and prevention.

High Device and Monitoring Service Costs

The mobile cardiac telemetry systems market still faces a cost barrier in healthcare systems that do not support subscription, bundled, or well-defined reimbursement models. Continuous monitoring requires devices, connectivity, physician interpretation, and round-the-clock staffing, which pushes the total service cost well above the level that many uninsured or cost-sensitive patients can absorb. The mobile cardiac telemetry systems market also carries a structural cost floor because attended surveillance requirements make labor and monitoring center overhead difficult to remove. This favors larger operators with scale, while smaller testing facilities face weaker economics and less room to price competitively. In practical terms, the mobile cardiac telemetry systems market remains easier to penetrate in insured settings than in public systems with tight procurement budgets. Even where clinical demand is clear, cost can delay adoption in primary care and community settings that are less familiar with billing and service workflows.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Assisted Signal Review and Workflow Automation
2. Reimbursement Expansion for Ambulatory and Home-Based Cardiac Monitoring
3. Clinical Training Gaps for Interpretation and Device Workflow

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Lead-based systems held 62.22% share in 2025, which kept them at the center of the mobile cardiac telemetry systems market because multi-lead configurations still offer stronger diagnostic resolution for arrhythmia classification. Their installed base also remains important, since lead-based systems fit more easily into existing interpretation workflows and hospital telemetry practices. In the mobile cardiac telemetry systems market, that combination of clinical familiarity and workflow compatibility continues to support demand from electrophysiologists and hospital-based cardiac teams. This means the mobile cardiac telemetry systems market still relies on lead-based devices for much of its current revenue base.

Patch-based systems, however, are projected to grow at a 13.45% CAGR through 2031, which makes them the faster-moving product line in the mobile cardiac telemetry systems market. Their appeal comes from simpler wearability, lower visibility on the body, and extended-use convenience, all of which can support adherence outside clinical settings. Over time, the mobile cardiac telemetry systems market is likely to move toward a mixed product structure, with patch formats taking more outpatient volume while lead-based systems remain important in complex and higher-acuity use cases.

Software accounted for 53.33% of the mobile cardiac telemetry systems market size in 2025, which shows how much value has shifted from hardware into analytics, workflow orchestration, and decision support. This part of the mobile cardiac telemetry systems industry carries strong strategic weight because data review, triage, and reporting now shape clinical efficiency as much as sensors do. As a result, software remains the clearest anchor for margin and differentiation in the mobile cardiac telemetry systems market.

Services are forecasted to grow at a 13.74% CAGR through 2031, which reflects rising demand for managed monitoring, reading-center support, and integration work around remote care pathways. The Heart Failure Society of America also emphasized that better outcomes depend on seamless data flow among devices, EHRs, and care teams, which supports the role of service and integration layers in the mobile cardiac telemetry systems market. In this setting, the mobile cardiac telemetry systems industry is moving toward business models where recurring platform services matter more than one-time device sales.

Complete Report Scope:

• By Product Type
  • Lead-Based Systems
  • Patch-Based Systems
• By Component
  • Hardware
  • Software
  • Services
• By Application
  • Arrhythmia Monitoring
  • Heart Disease Diagnosis
  • Post-Surgical Monitoring
  • Remote Patient Monitoring
  • Preventive Healthcare
• By End-User
  • Hospitals and Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 50.27% of the mobile cardiac telemetry systems market share in 2025, which kept it as the largest regional contributor. The United States supports this lead through established CPT billing pathways and a dense independent diagnostic testing facility structure that is already familiar with extended ambulatory monitoring. The 2026 CMS local coverage determination provides clearer coverage rules for temporary nontherapeutic ambulatory cardiac monitoring devices, which can reduce administrative friction and support broader prescribing patterns. That gives the mobile cardiac telemetry systems market a strong operating base in North America, where reimbursement, interpretation capacity, and workflow standardization are more mature than in most other regions. Canada and Mexico contribute less, but the regional structure still favors companies that can work at scale across reimbursement, monitoring operations, and provider integration.

Europe remained the second-largest geography in the mobile cardiac telemetry systems market, supported by established healthcare systems and ongoing demand for ambulatory cardiac surveillance. Germany, the United Kingdom, France, Italy, and Spain continue to shape regional volume, while tariff variation still limits consistency in adoption across countries. Biotronik's 2025 research partnership with Charite and the German Heart Center Foundation also points to Europe's importance as an innovation base for AI-supported digital cardiology.

Asia-Pacific is projected to be the fastest-growing region in the mobile cardiac telemetry systems market at a 15.36% CAGR through 2031. Growth is being supported by aging populations in Japan and South Korea, expanding cardiovascular disease burden in India and China, and continued health system interest in digital and home-based monitoring pathways. The mobile cardiac telemetry systems market in this region is still less mature than in North America, but the growth pace reflects a wider opening for remote care and ambulatory diagnostics. Entry conditions remain selective because approval standards and local operating requirements differ across major markets, which means companies need both regulatory readiness and service adaptability to scale effectively.

1. Abbott Laboratories
2. AliveCor
3. Applied Cardiac Systems, Inc.
4. BioTelemetry
5. Biotricity, Inc.
6. BIOTRONIK
7. Boston Scientific
8. Cardiosense, Inc.
9. Infobionic, Inc.
10. iRhythm Technologies
11. Koninklijke Philips
12. Medicalgorithmics S.A.
13. Medicomp, Inc.
14. Medtronic
15. Preventice Solutions, Inc.
16. ScottCare Cardiovascular Solutions, Inc.
17. Spacelabs Healthcare
18. Telerhythmics LLC
19. VitalConnect, Inc.
20. Zoll Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Cardiac Disease and Arrhythmia Detection Needs
  • 4.2.2 Shift to Continuous, Real-Time Remote Patient Monitoring
  • 4.2.3 AI-Assisted Signal Review and Workflow Automation
  • 4.2.4 Reimbursement Expansion for Ambulatory and Home-Based Cardiac Monitoring
  • 4.2.5 Integration With EHR, RPM, and Cloud Care Platforms
  • 4.2.6 Underused Primary Care and Post-Discharge Screening Pathways
• 4.3 Market Restraints
  • 4.3.1 High Device and Monitoring Service Costs
  • 4.3.2 Clinical Training Gaps for Interpretation and Device Workflow
  • 4.3.3 Patient Adherence Issues in Wearable Monitoring
  • 4.3.4 Integration Friction with Legacy Hospital IT and Data Governance Requirements
• 4.4 Supply/Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Lead-Based Systems
  • 5.1.2 Patch-Based Systems
• 5.2 By Component
  • 5.2.1 Hardware
  • 5.2.2 Software
  • 5.2.3 Services
• 5.3 By Application
  • 5.3.1 Arrhythmia Monitoring
  • 5.3.2 Heart Disease Diagnosis
  • 5.3.3 Post-Surgical Monitoring
  • 5.3.4 Remote Patient Monitoring
  • 5.3.5 Preventive Healthcare
• 5.4 By End-User
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Home Healthcare
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Diagnostic Laboratories
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 AliveCor, Inc.
  • 6.3.3 Applied Cardiac Systems, Inc.
  • 6.3.4 BioTelemetry, Inc.
  • 6.3.5 Biotricity, Inc.
  • 6.3.6 Biotronik SE and Co. KG
  • 6.3.7 Boston Scientific Corporation
  • 6.3.8 Cardiosense, Inc.
  • 6.3.9 Infobionic, Inc.
  • 6.3.10 iRhythm Technologies, Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Medicalgorithmics S.A.
  • 6.3.13 Medicomp, Inc.
  • 6.3.14 Medtronic plc
  • 6.3.15 Preventice Solutions, Inc.
  • 6.3.16 ScottCare Cardiovascular Solutions, Inc.
  • 6.3.17 Spacelabs Healthcare
  • 6.3.18 Telerhythmics LLC
  • 6.3.19 VitalConnect, Inc.
  • 6.3.20 ZOLL Medical Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment